This includes everything from locked server rooms to policies preventing shared usernames. The report emphasizes that a shared generic login destroys "Attributability" (the "A" in ALCOA).
Without TR 80, many labs mistakenly believe that a signed paper printout is sufficient. The report clarifies that without the raw data, the printout is "unattributable" and potentially incomplete.
TR-80 provides a risk-based framework for establishing, implementing, and maintaining a specifically for pharmaceutical quality control laboratories — though its principles apply to GxP environments more broadly. pda technical report 80
As the pharmaceutical industry continues to evolve, PDA TR 80 will remain a critical document for manufacturers, testing laboratories, and regulatory agencies. By understanding and implementing the guidance outlined in PDA TR 80, we can ensure the sterility and safety of parenteral and ophthalmic drug products, ultimately protecting public health and enhancing patient safety.
PDA TR 80 moves away from a "one-size-fits-all" audit checklist. Instead, it introduces a risk-based prioritization matrix. Labs are instructed to assess every instrument and process based on two variables: This includes everything from locked server rooms to
If you’d like, I can also summarize of TR-80 (e.g., how to implement audit trail review, or managing hybrid systems) based on known public content. Just let me know.
(Published: 2018)
The reviewer must look at the audit trail without knowing the final result (blinded review) to prevent confirmation bias (e.g., ignoring a weird integration because the result passed spec).
Are You Controlling Peak Integration to Ensure Data Integrity? The report clarifies that without the raw data,
(fully electronic data capture and storage).
The report has several benefits, including: